English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/158229
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

PDRG1 at the interface between intermediary metabolism and oncogenesis

AutorPajares, María A.
Palabras claveEpigenetic modifications
Glutathione
Methylation
Oncogenes
Intermediary metabolism
p53 and DNA damage-regulated gene 1
Protein complexes
R2TP/prefoldin complex
S-adenosylmethionine synthesis
Redox stress
Fecha de publicación26-nov-2017
EditorBaishideng Publishing Group
CitaciónWorld J Biol Chem 8(4): 175-186 (2017)
ResumenPDRG1 is a small oncogenic protein of 133 residues. In normal human tissues, the p53 and DNA damage-regulated gene 1 (PDRG1) gene exhibits maximal expression in the testis and minimal levels in the liver. Increased expression has been detected in several tumor cells and in response to genotoxic stress. High-throughput studies identified the PDRG1 protein in a variety of macromolecular complexes involved in processes that are altered in cancer cells. For example, this oncogene has been found as part of the RNA polymerase II complex, the splicing machinery and nutrient sensing machinery, although its role in these complexes remains unclear. More recently, the PDRG1 protein was found as an interaction target for the catalytic subunits of methionine adenosyltransferases. These enzymes synthesize S-adenosylmethionine, the methyl donor for, among others, epigenetic methylations that occur on the DNA and histones. In fact, downregulation of S-adenosylmethionine synthesis is the first functional effect directly ascribed to PDRG1. The existence of global DNA hypomethylation, together with increased PDRG1 expression, in many tumor cells highlights the importance of this interaction as one of the putative underlying causes for cell transformation. Here, we will review the accumulated knowledge on this oncogene, emphasizing the numerous aspects that remain to be explored.
Descripción16 p.-5 fig.-1 tab.
Versión del editorhttp://dx.doi.org/10.4331/wjbc.v8.i4.175
URIhttp://hdl.handle.net/10261/158229
DOI10.4331/wjbc.v8.i4.175
E-ISSN1949-8454
Aparece en las colecciones: (CIB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
WJBC_M. A. Pajares_2017.pdfArtículo principal5,98 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.